KL
Kalaris Therapeutics Inc (KLRS) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$1.97
+5.91%
Mkt Cap $65.65M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | — | — | — | -$0.56 | -$0.44 | +21.43% |
| Q1 2026 Mar 6, 2026 | — | — | — | -$0.56 | -$0.58 | -4.46% |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.66 | -$0.64 | +3.03% |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.51 | -$0.61 | -19.61% |
| Q2 2025 May 14, 2025 | — | — | — | -$0.78 | -$2.52 | -223.08% |
| Q1 2025 Mar 7, 2025 | — | — | — | -$2.76 | -$3.64 | -31.84% |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.14 | -$0.04 | +71.43% |
| Q2 2024 Jun 30, 2024 | — | — | — | -$2.37 | -$1.13 | +52.18% |
| Q1 2024 Mar 31, 2024 | — | — | — | -$3.62 | -$0.68 | +81.09% |
| Q4 2023 Dec 31, 2023 | — | — | — | -$9.84 | -$0.70 | +92.88% |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$8.94 | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$11.00 | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$10.15 | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$9.42 | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$11.39 | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$15.93 | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$15.77 | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$20.96 | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$16.62 | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$13.87 | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$11.44 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$9.36 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$13.42 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$4.11 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$3.30 | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$3.09 | — |
| Q3 2019 Sep 30, 2019 | — | — | — | — | -$2.57 | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$1.87 | — |
| Q1 2019 Mar 31, 2019 | — | $165.00K | — | — | -$0.89 | — |